SCHEMBL9839221

SCHEMBL9839221

CC(C)(C)[Si](C)(C)OCCSCc1cccnc1N(C(=O)Oc1ccccc1)c1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.41
ATM Q13315 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
NPSR1 Q6W5P4 2/20 0.36
RAB9A P51151 3/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TSHR P16473 1/20 0.34
LMNA P02545 1/20 0.32
NPC1 O15118 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
ALDH1A1 P00352 2/20 0.32
LIPE Q05469 2/20 0.31
CHRM2 P08172 1/20 0.31
CHRM4 P08173 1/20 0.31
CHRM5 P08912 1/20 0.31
CHRM1 P11229 1/20 0.31
CHRM3 P20309 1/20 0.31
F2 P00734 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9470118 0.90 POLB (0.32) L3MBTL1TSHRLMNAALDH1A1CHRM2
SCHEMBL9470286 0.71 DHODH (0.36) NPSR1RAB9AMEN1KMT2ANPC1
SCHEMBL14097540 0.64 ALDH1A1 (0.47) L3MBTL1RAB9AMEN1KMT2ALMNA
SCHEMBL21122067 0.64 BACE1 (0.41) CHRM2CHRM4CHRM5CHRM1CHRM3
SCHEMBL867886 0.63 L3MBTL1 (1.00) L3MBTL1ATMTDP1NPSR1RAB9A
SCHEMBL26129282 0.62 NPC1 (0.47) RAB9ANPC1
SCHEMBL8335738 0.61 KMT2A (0.39) L3MBTL1TDP1RAB9AKMT2ATSHR
SCHEMBL2812688 0.61 L3MBTL1 (0.58) L3MBTL1ATMTDP1NPSR1RAB9A
SCHEMBL4563495 0.61 SMN1; SMN2 (0.44) L3MBTL1RAB9AMEN1KMT2ATSHR
SCHEMBL7402519 0.61 NPSR1 (0.35) L3MBTL1ATMTDP1NPSR1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0419561-A1 HETEROBICYCLIC COMPOUNDS HAVING ANTIINFLAMMATORY ACTIVITY SCHERING CORPORATION (US) 1991-04-03 EP disclosed
WO-1989012637-A1 HETEROBICYCLIC COMPOUNDS HAVING ANTIINFLAMMATORY ACTIVITY SCHERING CORPORATION (US) 1989-12-28 WO disclosed
EP-0347698-A1 Heterobicyclic compounds having antiinflammatory activity SCHERING CORPORATION (US) 1989-12-27 EP disclosed